天坛生物
(600161)
| 流通市值：253.30亿 | | | 总市值：253.30亿 |
| 流通股本：19.77亿 | | | 总股本：19.77亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 3,852,097,635.83 | 2,595,368,216.39 | 1,141,703,634.53 | 6,168,036,314.63 |
| 营业总成本 | 3,115,605,323.5 | 2,083,907,451.48 | 949,243,685.91 | 4,315,509,249.08 |
| 其他经营收益 | | | | |
| 营业利润 | 754,798,111.92 | 522,110,927.39 | 223,388,690.74 | 1,837,307,995.59 |
| 利润总额 | 750,536,000.78 | 520,850,668.28 | 223,217,439.74 | 1,822,723,792.4 |
| 净利润 | 593,865,915.15 | 414,563,879.92 | 179,093,258.66 | 1,489,882,179.7 |
| 每股收益 | | | | |
| 其他综合收益 | 4,797,562.76 | 4,797,562.76 | 1,620,701.85 | - |
| 综合收益总额 | 598,663,477.91 | 419,361,442.68 | 180,713,960.51 | 1,489,882,179.7 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 8,501,623,174.03 | 8,741,538,976.24 | 8,353,096,535.09 | 8,272,166,627.47 |
| 非流动资产: | | | | |
| 非流动资产合计 | 8,304,186,971.26 | 8,303,943,627.69 | 8,322,324,311.45 | 8,310,848,974.04 |
| 资产总计 | 16,805,810,145.29 | 17,045,482,603.93 | 16,675,420,846.54 | 16,583,015,601.51 |
| 流动负债: | | | | |
| 流动负债合计 | 1,046,579,503.09 | 1,251,980,728.64 | 947,296,437.83 | 1,034,639,712.24 |
| 非流动负债: | | | | |
| 非流动负债合计 | 214,144,102.69 | 221,750,769.2 | 231,164,712.49 | 232,130,153.56 |
| 负债合计 | 1,260,723,605.78 | 1,473,731,497.84 | 1,178,461,150.32 | 1,266,769,865.8 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 11,871,344,289.95 | 11,940,006,290.26 | 11,862,653,860.46 | 11,735,167,115.14 |
| 股东权益合计 | 15,545,086,539.51 | 15,571,751,106.09 | 15,496,959,696.22 | 15,316,245,735.71 |
| 负债和股东权益合计 | 16,805,810,145.29 | 17,045,482,603.93 | 16,675,420,846.54 | 16,583,015,601.51 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,767,465,466.58 | 2,458,849,522.5 | 1,027,327,105.69 | 4,815,402,695.77 |
| 经营活动现金流出小计 | 3,357,301,350.56 | 2,169,493,007.32 | 1,042,835,301.72 | 4,476,656,037.14 |
| 经营活动产生的现金流量净额 | 410,164,116.02 | 289,356,515.18 | -15,508,196.03 | 338,746,658.63 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 853,982,762.03 | 551,842,289.41 | 541,463,589.7 | 746,536,293.99 |
| 投资活动现金流出小计 | 1,264,407,581.43 | 1,141,623,365.7 | 987,146,547.77 | 622,181,434.31 |
| 投资活动产生的现金流量净额 | -410,424,819.4 | -589,781,076.29 | -445,682,958.07 | 124,354,859.68 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 317,452,369.4 | 232,602,565.12 | 86,953,347.1 | 286,925,081.38 |
| 筹资活动现金流出小计 | 387,897,745.38 | 33,815,191.38 | 1,101,139.67 | 729,320,770.18 |
| 筹资活动产生的现金流量净额 | -70,445,375.98 | 198,787,373.74 | 85,852,207.43 | -442,395,688.8 |
| 汇率变动对现金及现金等价物的影响 | -39,436.53 | -29,715.9 | -14,958.93 | -28,934.14 |
| 现金及现金等价物净增加额 | -70,745,515.89 | -101,666,903.27 | -375,353,905.6 | 20,676,895.37 |
| 期末现金及现金等价物余额 | 1,372,852,284.52 | 1,341,930,897.14 | 1,068,243,894.81 | 1,443,597,800.41 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -101,666,903.27 | - | 20,676,895.37 |
最新报告期：2026-10-30| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中国银河 | 程培,宋丽莹 | 0.32 | 0.37 | 0.42 | 2026-10-30 |
| 中信建投 | 汤然,刘若飞,贺菊颖 | 0.39 | 0.49 | 0.62 | 2026-09-14 |
| 中信建投 | 汤然,刘若飞,贺菊颖 | 0.39 | 0.49 | 0.62 | 2026-09-06 |
| 开源证券 | 阮帅,余汝意 | 0.49 | 0.59 | 0.65 | 2026-08-31 |